Showing 1 - 10 of 109
In this context, higher education as well as research and development (R&D) have long since ceased to be purely the domain of the developed Western economies. Numerous regions of the world, some in the emerging markets in particular – the often-cited BRIC countries – are catching...
Persistent link: https://www.econbiz.de/10009653328
Introducing patent rights in developing country markets might stimulate greater R and D investment targeting their …
Persistent link: https://www.econbiz.de/10008512485
This paper highlights the status of the Indian biopharmaceutical industry and also makes a comparison with the global scenario. It also discusses the current situation regarding patenting biopharmaceuticals in India. [GIDR WP no. 168].
Persistent link: https://www.econbiz.de/10005487727
investment. The study locates, nevertheless, a few sectors that display substantial vibrancy that in turn leave scope for …
Persistent link: https://www.econbiz.de/10009386042
There is a strong feeling among especially the West that India is becoming very innovative. The study will take the reader through the empirical evidence on whether this is indeed the case since the reform process of 1991. The actual innovative performance of India’s economy since...
Persistent link: https://www.econbiz.de/10008512436
How does innovation impact on development? How, and under what conditions, do entrepreneurs in developing countries … innovate? And what can be done to support innovation by entrepreneurs in developing countries? This policy brief addresses … these questions and explains the relationship between entrepreneurship, innovation and development. Policy lessons are drawn …
Persistent link: https://www.econbiz.de/10009323949
The study attempts to examine the impact of remittances on macroeconomic activities (private consumption and investment …
Persistent link: https://www.econbiz.de/10005025321
A new survey finds that only 17 drugs are under active development for maternal health indications, which is less than 3% of the pipeline in cardiovascular health (660 drugs). The international agencies have forgotten pregnant women. Given the unacceptably high number of maternal and perinatal...
Persistent link: https://www.econbiz.de/10005341686
This paper attempts to identify the factors that determine the export competitiveness of firms in the Indian pharmaceutical industry. Our findings suggest that the competitiveness of firms depends not only on firm specific advantages but also on government fiscal incentives. Among the firm...
Persistent link: https://www.econbiz.de/10005341701
The paper analyzes the determinants of internationalisation, defined in terms of export intensity and overseas investments, of the IT firms in India. In particular, the paper examines the role of technology sourcing, both internal (in-house R&D) and external (technology imports), in determining...
Persistent link: https://www.econbiz.de/10005341763